PTJ
TMDX icon

Paul Tudor Jones’s Transmedics TMDX Stock Holding History

Paul Tudor Jones’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.38M Buy
20,800
+12,700
+157% +$1.08M ﹤0.01% 2192
2026
Q1 		$805K Sell
8,100
-2,900
-26% -$378K ﹤0.01% 2510
2025
Q4 		$1.34M Sell
11,000
-5,800
-35% -$728K ﹤0.01% 2083
2025
Q3 		$1.88M Buy
16,800
+2,700
+19% +$316K ﹤0.01% 1843
2025
Q2 		$1.89M Buy
14,100
+8,900
+171% +$977K ﹤0.01% 1695
2025
Q1 		$350K Sell
5,200
-11,700
-69% -$805K ﹤0.01% 2504
2024
Q4 		$1.05M Buy
16,900
+14,300
+550% +$1.33M ﹤0.01% 1694
2024
Q3 		$408K Buy
+2,600
New +$401K ﹤0.01% 2151

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Paul Tudor Jones's TMDX Position: Q2 2026 in Review

Paul Tudor Jones sold out of Transmedics (TMDX) in Q2 2026, closing a stake of 40,217 shares — an estimated $3.4M sold.

Paul Tudor Jones first reported a position in TMDX in Q2 2022 and held it in 12 quarters. The position peaked at $16.6M in Q2 2025. 371 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Paul Tudor Jones reported no remaining Transmedics position as of Q2 2026 after selling out during the quarter.
  • Paul Tudor Jones sold 40,217 Transmedics shares in Q2 2026, an estimated $3.4M.
  • Paul Tudor Jones first reported a position in Transmedics in Q2 2022 and held it in 12 quarters.
  • Paul Tudor Jones's Transmedics position peaked at $16.6M in Q2 2025.
  • 371 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.